Detalhe da pesquisa
1.
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.
Hepatology
; 78(4): 1223-1239, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162151
2.
Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study.
Am J Transplant
; 18(6): 1435-1446, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29237235
3.
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial.
Contemp Clin Trials
; 88: 105889, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31731005
4.
Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study.
Transplantation
; 101(10): 2612-2620, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28333860